Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2022-12-21 00:00:00 ET · period of report 2022-12-19 · accession 0001209191-22-062287 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-21 | 2022-12-19 | SRPT | BEHRENS M KATHLEEN | Dir | M - OptEx | $34.92 | +20.0K | 158.5K | +14% | +$698.4K |
| D | 2022-12-21 | 2022-12-19 | SRPT | BEHRENS M KATHLEEN | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-19 | M | A | 20,000 | $34.92 | 158,470 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-12-19 | M | D | 20,000 | $0.00 | 0 | D | $34.92 · 2014-06-04 to 2023-06-04 | 20,000 Common Stock |